Biotech Sector Remains Undervalued - Oppenheimer
Go back to Biotech Sector Remains Undervalued - Oppenheimer| iShares Nasdaq Biotechnology Index Fund (NASDAQ: IBB) | Delayed: 186.41 -3.55 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $189.96 | 52 Week High | $343.87 | |||
| Open | $189.14 | 52 Week Low | $240.03 | |||
| Day High | $189.29 | P/E | N/A | |||
| Day Low | $184.78 | EPS | $0.00 | |||
| Volume | 1,609,655 | |||||
| SPDR S&P BIOTECH ETF (NYSE: XBI) | Delayed: 147.01 -4.45 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.46 | 52 Week High | $73.80 | |||
| Open | $151.20 | 52 Week Low | $44.16 | |||
| Day High | $151.77 | P/E | N/A | |||
| Day Low | $146.00 | EPS | $0.00 | |||
| Volume | 8,043,800 | |||||
